相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study
Andrea Arfe et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study
Andrea Arfe et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Association of NSAID Use With Risk of Bleeding and Cardiovascular Events in Patients Receiving Antithrombotic Therapy After Myocardial Infarction
Anne-Marie Schjerning Olsen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change
John E. Cornell et al.
ANNALS OF INTERNAL MEDICINE (2014)
Correction: Drug-Induced Acute Myocardial Infarction: Identifying ‘Prime Suspects’ from Electronic Healthcare Records-Based Surveillance System
Preciosa M. Coloma et al.
PLoS One (2014)
Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues?
Vera E. Valkhoff et al.
BMC PEDIATRICS (2013)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
N. Bhala et al.
LANCET (2013)
Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies
Cristina Varas-Lorenzo et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries
Preciosa M. Coloma et al.
BMJ OPEN (2013)
Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction A Nationwide Cohort Study
Anne-Marie Schjerning Olsen et al.
CIRCULATION (2011)
Cardiovascular and Gastrointestinal Safety of NSAIDs: A Systematic Review of Meta-Analyses of Randomized Clinical Trials
F. Salvo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project
Preciosa M. Coloma et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies
Patricia McGettigan et al.
PLOS MEDICINE (2011)
Privacy-Maintaining Propensity Score-Based Pooling of Multiple Databases Applied to a Study of Biologics
Jeremy A. Rassen et al.
MEDICAL CARE (2010)
Cardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart Disease
Wayne A. Ray et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2009)
Role of Dose Potency in the Prediction of Risk of Myocardial Infarction Associated With Nonsteroidal Anti-Inflammatory Drugs in the General Population
Luis Alberto Garcia Rodriguez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Establishment of a pharmacoepidemiological database in Germany: Methodological potential, scientific value and practical limitations
Iris Pigeot et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Diclofenac and acute myocardial infarction in patients with no major risk factors
Susan S. Jick et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident
N. S. Abraham et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research
James D. Lewis et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Use of nonsteroidal Antiinflammatory drugs an update for clinicians - A scientific statement from the American Heart Association
Elliott M. Antman et al.
CIRCULATION (2007)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
Christopher P. Cannon et al.
LANCET (2006)
NSAID use and the risk of hospitalization for first myocardial infarction in the general population:: a nationwide case-control study from Finland
Arja Helin-Salmivaara et al.
EUROPEAN HEART JOURNAL (2006)
Use of first- and second-generation cyclooxygenase-2 selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction
F Andersohn et al.
CIRCULATION (2006)
Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs -: A population-based case-control study
SP Johnsen et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice
MC Simmonds et al.
CLINICAL TRIALS (2005)
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial
ME Farkouh et al.
LANCET (2004)
Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs - A review
E Rahme et al.
DRUG SAFETY (2004)
Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery
E Ott et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2003)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
FE Silverstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
